Largest pharmaceutical companies in the United States by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
AbbVie leads the 24 pharmaceutical companies in the United States ranked by total debt, at THB 2.29T, ahead of Pfizer (THB 2.2T) and Merck & Co (THB 1.67T). Figures as of 20 Nov 2026, 14:27 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AbbVieTHB 2.29T
- Median
- THB 77.6B
- Combined market value
- THB 126.57T
- Countries
- 1
- Not ranked
- 20no total debt on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total debt ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | THB 2.29T | THB 16.98T | THB 9,606.34 | 0.86% down | 20% up | ||
| 2 | PfizerPFE · Health Care | THB 2.2T | THB 5.32T | THB 933.06 | 1.85% down | 10% up | ||
| 3 | Merck & CoMRK · Health Care | THB 1.67T | THB 11.09T | THB 4,499.60 | 3.61% down | 36% up | ||
| 4 | Johnson & JohnsonJNJ · Health Care | THB 1.62T | THB 21.79T | THB 9,050.70 | 2.04% down | 31% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | THB 1.53T | THB 4.04T | THB 1,976.56 | 2.05% down | 26% up | ||
| 6 | Eli LillyLLY · Health Care | THB 1.44T | THB 40.77T | THB 45,775.95 | 2.29% down | 28% up | ||
| 7 | ViatrisVTRS · Health Care | THB 488.2B | THB 772.2B | THB 673.53 | 1.97% down | 90% up | ||
| 8 | Abbott LaboratoriesABT · Health Care | THB 438B | THB 6.09T | THB 3,519.12 | 0.58% down | 19% down | ||
| 9 | ZoetisZTS · Health Care | THB 306.3B | THB 1.11T | THB 2,737.17 | 5.59% down | 34% down | ||
| 10 | Royalty PharmaRPRX · Health Care | THB 303.3B | THB 1.32T | THB 2,294.35 | 1.38% down | 74% up | ||
| 11 | Elanco Animal HealthELAN · Health Care | THB 136.1B | THB 445.2B | THB 890.71 | 1.54% down | 18% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | THB 87.1B | THB 252.5B | THB 724.69 | 2.24% down | 79% up | ||
| 13 | BridgeBio PharmaBBIO · Health Care | THB 68B | THB 516B | THB 2,648.74 | 0.22% up | 15% up | ||
| 14 | Regeneron PharmaceuticalsREGN · Health Care | THB 67.3B | THB 3.24T | THB 31,282.76 | 2.35% down | 22% up | ||
| 15 | Ionis PharmaceuticalsIONS · Health Care | THB 61.4B | THB 153.6B | THB 922.21 | 0.62% down | 64% down | ||
| 16 | InsmedINSM · Health Care | THB 18.5B | THB 1.07T | THB 4,894.30 | 20.58% up | 27% down | ||
| 17 | Madrigal PharmaceuticalsMDGL · Health Care | THB 11.5B | THB 312.2B | THB 13,441.55 | 0.34% down | 28% down | ||
| 18 | Legend BiotechLEGN · Health Care | THB 10.8B | THB 105.8B | THB 545.47 | 0.92% down | 43% down | ||
| 19 | CytokineticsCYTK · Health Care | THB 9.7B | THB 242.9B | THB 1,743.46 | 0.27% up | 21% down | ||
| 20 | TG TherapeuticsTGTX · Health Care | THB 8.3B | THB 332.2B | THB 2,198.13 | 1.88% down | 103% up | ||
| 21 | Cogent BiosciencesCOGT · Health Care | THB 7.6B | THB 163.5B | THB 939.83 | 0.25% down | 25% down | ||
| 22 | Axsome TherapeuticsAXSM · Health Care | THB 6.4B | THB 241.8B | THB 4,596.84 | 1.25% up | 9% down | ||
| 23 | Rhythm PharmaceuticalsRYTM · Health Care | THB 3.7B | THB 274.4B | THB 3,957.18 | 1.88% down | 15% up | ||
| 24 | Definium TherapeuticsDFTX · Health Care | THB 1.4B | THB 136.7B | THB 998.78 | 1.24% up | 176% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 33.8800 THB). 20 companies have no total debt on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by total debt?
AbbVie (THB 2.29T), Pfizer (THB 2.2T) and Merck & Co (THB 1.67T) are the top three of the 24 pharmaceutical companies in the United States ranked by total debt as of 20 Nov 2026, 14:27 UTC.
How many pharmaceutical companies in the United States are in this ranking?
24 are ranked by total debt. 20 more have no total debt on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 24 pharmaceutical companies in the United States ranked by total debt have a combined market value of THB 126.57T as of 20 Nov 2026, 14:27 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.